Vaccines (Feb 2021)

Enterovirus A71 Vaccines

  • Mei-Ling Li,
  • Shin-Ru Shih,
  • Blanton S. Tolbert,
  • Gary Brewer

DOI
https://doi.org/10.3390/vaccines9030199
Journal volume & issue
Vol. 9, no. 3
p. 199

Abstract

Read online

Enterovirus A71 (EV-A71) is a major causative agent of hand, foot, and mouth disease (HFMD) and herpangina. Moreover, EV-A71 infection can lead to neurological complications and death. Vaccination is the most efficient way to control virus infection. There are currently three inactivated, whole EV-A71 vaccines licensed by the China NMPA (National Medical Products Administration). Several other types of vaccines, such as virus-like particles and recombinant VP1 (capsid protein), are also under development. In this review, we discuss recent advances in the development of EV-A71 vaccines.

Keywords